BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives Consensus Rating of "Buy" from Analysts

Key Points

• Analysts consensus: Buy — 17 analysts cover BrightSpring (14 buys, 2 strong buys, 1 hold) with an average 12‑month price target of $45.50 and recent price-target upgrades (Mizuho $52, Wells Fargo $50).
• Latest quarter: revenue beat at $3.55 billion (vs. $3.38B estimate) and revenue rose 29.3% year‑over‑year, while EPS was $0.33, missing consensus by $0.01.
• Insider activity: corporate insiders sold 285,000 shares (~$11.7M) in the past 90 days; insiders collectively own about 3.4% of the company.

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) has been assigned a consensus rating of "Buy" from the seventeen ratings firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $45.50.

Several equities analysts have recently commented on the company. Mizuho boosted their target price on shares of BrightSpring Health Services from $50.00 to $52.00 and gave the company an "outperform" rating in a research report on Wednesday, March 18th. Wells Fargo & Company boosted their price objective on shares of BrightSpring Health Services from $43.00 to $50.00 and gave the company an "overweight" rating in a report on Monday, March 2nd. Cantor Fitzgerald set a $49.00 target price on shares of BrightSpring Health Services in a research report on Monday, March 2nd. Zacks Research raised shares of BrightSpring Health Services from a "hold" rating to a "strong-buy" rating in a report on Tuesday, March 3rd. Finally, CJS Securities upgraded shares of BrightSpring Health Services to a "strong-buy" rating in a research report on Thursday, December 11th.

BrightSpring Health Services Price Performance

NASDAQ:BTSG opened at $43.10 on Friday. The stock has a market capitalization of $8.34 billion, a PE ratio of 48.98, a P/E/G ratio of 0.57 and a beta of 2.03. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32. The firm has a fifty day simple moving average of $40.76 and a 200 day simple moving average of $36.35. BrightSpring Health Services has a 1-year low of $15.48 and a 1-year high of $45.59.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by ($0.01). BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The business had revenue of $3.55 billion during the quarter, compared to the consensus estimate of $3.38 billion. During the same quarter last year, the company posted $0.11 EPS. The firm's revenue was up 29.3% on a year-over-year basis. On average, research analysts expect that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Jon B. Rousseau sold 220,000 shares of the business's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the completion of the transaction, the insider owned 1,023,880 shares of the company's stock, valued at approximately $42,132,662. The trade was a 17.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jennifer A. Phipps sold 35,000 shares of BrightSpring Health Services stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,440,250.00. Following the completion of the transaction, the chief financial officer owned 196,840 shares in the company, valued at approximately $8,099,966. This represents a 15.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 285,000 shares of company stock worth $11,727,750 over the last ninety days. Corporate insiders own 3.40% of the company's stock.

Institutional Trading of BrightSpring Health Services

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Lisanti Capital Growth LLC acquired a new stake in BrightSpring Health Services during the 3rd quarter worth approximately $1,959,000. Federated Hermes Inc. increased its position in BrightSpring Health Services by 44.8% in the 3rd quarter. Federated Hermes Inc. now owns 319,200 shares of the company's stock valued at $9,436,000 after acquiring an additional 98,745 shares during the period. Prescott Group Capital Management L.L.C. acquired a new position in BrightSpring Health Services in the 3rd quarter valued at approximately $887,000. Ellsworth Advisors LLC bought a new position in shares of BrightSpring Health Services during the third quarter valued at $983,000. Finally, Bailard Inc. bought a new position in shares of BrightSpring Health Services during the third quarter valued at $378,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.